Whitehawk Therapeutics (WHWK) Other financing activities (2016 - 2025)
Whitehawk Therapeutics (WHWK) reported Other financing activities of $5.5 million for Q4 2025, up 32741.18% year-over-year from N/an in Q4 2024, and up 216.92% on a QoQ basis from -$4.7 million in Q2 2025.
Whitehawk Therapeutics (WHWK) has 9 years of Other financing activities data on file, last reported at $5.5 million in Q4 2025.
- Quarterly Other financing activities rose 32741.18% year-over-year to $5.5 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $803000.0 (down 83.35% YoY) and the FY2025 annual result came in at $5.6 million, changed N/A from the prior year.
- Other financing activities climbed to $5.5 million in Q4 2025 per WHWK's latest filing, from -$4.7 million in the prior quarter.
- Across five years, Other financing activities topped out at $5.5 million in Q4 2025 and bottomed at -$4.7 million in Q2 2025.
- The 5-year median for Other financing activities is $41500.0 (2023), against an average of $589800.0.
- The widest annual swing landed in 2024, when Other financing activities slumped 150.0%; it then soared 32741.18% in 2025.
- Tracing WHWK's Other financing activities over 5 years: stood at -$1000.0 in 2021, then surged by 11500.0% to $114000.0 in 2022, then slumped by 70.18% to $34000.0 in 2023, then tumbled by 150.0% to -$17000.0 in 2024, then soared by 32741.18% to $5.5 million in 2025.
- Per Business Quant, the three latest WHWK Other financing activities figures stand at $5.5 million (Q4 2025), -$4.7 million (Q2 2025), and $4.8 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.55 Mn |
| Dec 31, 2025 | 5.55 Mn |
| Jun 30, 2025 | -4.75 Mn |
| Jun 30, 2025 | -4.75 Mn |
| Mar 31, 2025 | 4.82 Mn |
| Mar 31, 2025 | 4.82 Mn |
| Dec 31, 2024 | -17,000.00 |
| Dec 31, 2024 | -17,000.00 |
| Sep 30, 2024 | 17,000.00 |
| Sep 30, 2024 | 17,000.00 |
| Dec 31, 2023 | 34,000.00 |
| Dec 31, 2023 | 34,000.00 |
| Sep 30, 2023 | 77,000.00 |
| Sep 30, 2023 | 77,000.00 |
| Jun 30, 2023 | 49,000.00 |
| Jun 30, 2023 | 49,000.00 |
| Dec 31, 2022 | 114,000.00 |
| Dec 31, 2022 | 114,000.00 |
| Sep 30, 2021 | -1,000.00 |
| Sep 30, 2021 | -1,000.00 |
| Sep 30, 2020 | 292,000.00 |
| Sep 30, 2020 | 292,000.00 |
| Sep 30, 2018 | 409,054.00 |
| Sep 30, 2018 | 409,054.00 |
| Jun 30, 2018 | 3.09 Mn |
| Jun 30, 2018 | 3.09 Mn |
| Mar 31, 2017 | 3.08 Mn |
| Mar 31, 2017 | 3.08 Mn |
| Dec 31, 2016 | 125,935.00 |
| Dec 31, 2016 | 125,935.00 |